For: | You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Chen HY, Yu L, Tang BZ, Huang JH. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(7): 1112-1119 [PMID: 18286696 DOI: 10.3748/wjg.14.1112] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i7/1112.htm |
Number | Citing Articles |
1 |
Y. Shi, Y. Lan, F. Cao, Y. Teng, L. Li, F. Wang, J. Li, J. Zhou, Y. Li. Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patients. Journal of Viral Hepatitis 2014; 21(7) doi: 10.1111/jvh.12236
|
2 |
Mingtao Quan, Lezhi Li, Xiaoli Yuan, Zhixia Jiang, Xuyao Wang, Hualian Wu, Xiaojuan Li. Influence of multiple factors on the incidence of occupational blood and body fluid exposures in health care workers in Guizhou, China: A structural equation modeling approach. American Journal of Infection Control 2015; 43(11): e73 doi: 10.1016/j.ajic.2015.07.014
|
3 |
Arghavan Asghari, Fatemeh Jafari, Maryam Jameshorani, Hossein Chiti, Mohsen Naseri, Anahita Ghafourirankouhi, Omid Kooshkaki, Alireza Abdshah, Negin Parsamanesh. Vitamin D role in hepatitis B: focus on immune system and genetics mechanism. Heliyon 2022; 8(11): e11569 doi: 10.1016/j.heliyon.2022.e11569
|
4 |
Hyosun Cho, Hyojeung Kang, Hwan Lee, Chang Kim. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis. International Journal of Molecular Sciences 2017; 18(7): 1517 doi: 10.3390/ijms18071517
|
5 |
Yong Zhao, Ling Xiang Kong, Feng Shi Feng, Jiayin Yang, Guo Wei. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09433-3
|
6 |
I. P. Balmasova, R. I. Sepiashvili, E. S. Malova. MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B. Journal of microbiology, epidemiology and immunobiology 2016; 93(2): 119 doi: 10.36233/0372-9311-2016-2-119-126
|
7 |
L. Boglione, A. D'Avolio, G. Cariti, M. G. Milia, M. Simiele, A. De Nicolò, V. Ghisetti, G. Di Perri. Sequential therapy with entecavir and PEG‐INF in patients affected by chronic hepatitis B and high levels of HBV‐DNA with non‐D genotypes. Journal of Viral Hepatitis 2013; 20(4) doi: 10.1111/jvh.12018
|
8 |
Prashant Pandey, Divya Setya, Shweta Ranjan, Supriya Kumari, Dharmender Kumar. Correlation between Hepatitis B Viral Load and Hepatitis B Surface Antigen Levels in Asymptomatic Seropositive Blood Donors. Global Journal of Transfusion Medicine 2023; 8(2): 186 doi: 10.4103/gjtm.gjtm_12_23
|
9 |
R. S. Pandey, V. K. Dixit. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B. Journal of Drug Targeting 2010; 18(4): 282 doi: 10.3109/10611860903450015
|
10 |
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis B. World Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
|
11 |
Hui Zhang, Jianchun Xian, Yang Li, Li Xiao, Lu Wang, Muhammad Zia-Ul-Haq. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1889628
|
12 |
Christian A. Engell, Vinh Philip Pham, Robert S. Holzman, Judith A. Aberg. Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients. ISRN Gastroenterology 2011; 2011: 1 doi: 10.5402/2011/405390
|
13 |
Apostolos Koffas, Manoj Kumar, Upkar S. Gill, Ankur Jindal, Patrick T. F. Kennedy, S. K. Sarin. Chronic hepatitis B: the demise of the ‘inactive carrier’ phase. Hepatology International 2021; 15(2): 290 doi: 10.1007/s12072-021-10137-2
|
14 |
Marina Manea, Ion Mărunțelu, Ileana Constantinescu. Extended analysis on peripheral blood cytokines correlated with hepatitis B virus viral load in chronically infected patients – a systematic review and meta-analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1429926
|
15 |
Ayaid Khadem Zgair, Jenan A. Ghafil, Razaq H E Al‐Sayidi. Direct role of antibody‐secreting B cells in the severity of chronic hepatitis B. Journal of Medical Virology 2015; 87(3): 407 doi: 10.1002/jmv.24067
|
16 |
Nesa Shokoohifar, Salman Ahmady-Asbchin, Sima Besharat, Fatemeh Roudbari, Saeed Mohammadi, Taghi Amiriani, Behnaz Khodabakhshi, Alireza Norouzi, Iman Shahabinasab. The Impaired Balance of CD4+/CD8+ Ratio in Patients with Chronic Hepatitis B. Hepatitis Monthly 2020; 20(1) doi: 10.5812/hepatmon.96799
|
17 |
He Liu, Mei Li, Mingjuan Jin, Fangyuan Jing, Hui Wang, Kun Chen. Public awareness of three major infectious diseases in rural Zhejiang province, China: a cross-sectional study. BMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-192
|
18 |
Lucio Boglione, Jessica Cusato, Giuseppe Cariti, Giovanni Di Perri, Antonio D'Avolio. The E genotype of hepatitis B: Clinical and virological characteristics, and response to interferon. Journal of Infection 2014; 69(1): 81 doi: 10.1016/j.jinf.2014.02.018
|
19 |
Hongyan Wang, Di Wu, Xiaofeng Wang, Guang Chen, Yuanya Zhang, Weiming Yan, Xiaoping Luo, Meifang Han, Qin Ning. Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways. Biological Chemistry 2016; 397(11): 1173 doi: 10.1515/hsz-2015-0290
|
20 |
Sukriti Sukriti, Nirupma Trehan Pati, Sujoy Bose, Syed S. Hissar, Shiv Kumar Sarin. Impaired Antigen Processing and Presentation Machinery is Associated with Immunotolerant State in Chronic Hepatitis B Virus Infection. Journal of Clinical Immunology 2010; 30(3): 419 doi: 10.1007/s10875-010-9379-4
|